Toll Free: 1 866 833 3234

Category: NASDAQ

NASDAQ And NYSE American Shareholder Approval Requirements– Change Of Control

Nasdaq and the NYSE American both have rules requiring listed companies to receive shareholder approval prior to issuing securities in an amount of 20% or more of their outstanding common stock or voting power or prior to completing transactions which will result in a change of control of the company.  Nasdaq Rule 5635 sets forth the circumstances under which shareholder… Continue reading “NASDAQ And NYSE American Shareholder Approval Requirements– Change Of Control”

NYSE American Compliance Guidance MEMO

In January, NYSE Regulation sent out its yearly Compliance Guidance Memo to NYSE American listed companies. The annual letter updates companies on any rule changes from the year and reminds companies of items the NYSE deems important enough to warrant such a reminder. The only new item in this year’s letter relates to advance notice of stock dividends and distributions. Effective… Continue reading “NYSE American Compliance Guidance MEMO”

SEC Cautionary Statement on Audits of Public Companies Operating in China

Eight years following the crash of the Chinese reverse merger boom and a slew of SEC enforcement proceedings, the SEC is once again concerned with the financial reporting by U.S. listed companies with operations based in China. In December 2018, the SEC issued a cautionary public statement from SEC Chair Jay Clayton, SEC Chief Accountant Wes… Continue reading “SEC Cautionary Statement on Audits of Public Companies Operating in China”

An IPO Without The SEC

On January 23, 2019, biotechnology company Gossamer Bio, Inc., filed an amended S-1 pricing its $230 million initial public offering, taking advantage of a rarely used SEC Rule that will allow the S-1 to go effective, and the IPO to be completed, 20 days from filing, without action by the SEC.  Since the government shutdown, several companies have opted to proceed with the… Continue reading “An IPO Without The SEC”

Nasdaq Amends Its 20% Dilution Shareholder Approval Rule

Effective September 26, 2018, Nasdaq amended Rule 5635(d) to provide greater flexibility and certainty for companies to determine when a shareholder vote is necessary to approve a transaction that would result in the issuance of 20% or more of the outstanding common stock or 20% or more of outstanding voting power in a PIPE or similar private placement financing… Continue reading “Nasdaq Amends Its 20% Dilution Shareholder Approval Rule”

NASDAQ Issues Report Advocating for The U.S. Public Markets

Before SEC Commissioner Michael Piwowar’s May 16, 2017, speech at the SEC-NYU Dialogue on Securities Market Regulation regarding the U.S. IPO Market (see summary HERE), and SEC Chair Jay Clayton’s July 12, 2017, speech to the Economic Club of New York (see summary HERE), the topic of the U.S. IPO markethad already gained significant market attention. Earlier this year, NASDAQ… Continue reading “NASDAQ Issues Report Advocating for The U.S. Public Markets”

SEC Adopts The T+2 Trade Settlement Cycle

Introduction and brief summary of the rule On March 22, 2017, the SEC adopted a rule amendment shortening the standard settlement cycle for broker-initiated trade settlements from three business days from the trade date (T+3) to two business days (T+2). The change is designed to help enhance efficiency and reduce risks, including credit, market and liquidity risks,… Continue reading “SEC Adopts The T+2 Trade Settlement Cycle”